Rhythm Pharmaceuticals, Inc.
RYTM
$104.46
$3.073.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 416.05M | 291.03M | 314.49M | 320.57M | 298.39M |
| Total Receivables | 33.03M | 26.12M | 17.83M | 18.51M | 19.31M |
| Inventory | 22.11M | 18.87M | 19.32M | 18.74M | 13.90M |
| Prepaid Expenses | 23.61M | 24.66M | 17.66M | -- | 8.75M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 16.38M | -- |
| Total Current Assets | 494.80M | 360.68M | 369.29M | 374.20M | 340.34M |
|
|
|||||
| Total Current Assets | 494.80M | 360.68M | 369.29M | 374.20M | 340.34M |
| Net Property, Plant & Equipment | 3.40M | 3.56M | 3.83M | 4.11M | 4.39M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.53M | 5.75M | 5.96M | 6.17M | 6.39M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.14M | 2.75M | 7.61M | 7.79M | 12.45M |
| Total Assets | 506.87M | 372.73M | 386.69M | 392.27M | 363.57M |
|
|
|||||
| Total Accounts Payable | 13.63M | 15.98M | 11.91M | 12.33M | 4.89M |
| Total Accrued Expenses | 81.06M | 64.81M | 53.51M | 58.31M | 50.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.18M | 4.29M | 1.81M | 1.54M | -- |
| Total Finance Division Other Current Liabilities | 3.40M | 44.38M | 44.58M | 43.34M | 42.24M |
| Total Other Current Liabilities | 3.40M | 44.38M | 44.58M | 43.34M | 42.24M |
| Total Current Liabilities | 104.27M | 129.46M | 111.82M | 115.52M | 97.61M |
|
|
|||||
| Total Current Liabilities | 104.27M | 129.46M | 111.82M | 115.52M | 97.61M |
| Long-Term Debt | 103.41M | 106.01M | 107.93M | 108.27M | 109.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.52M | 3.68M | 3.84M | 3.94M | 4.03M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 211.19M | 239.15M | 223.60M | 227.72M | 210.88M |
|
|
|||||
| Common Stock & APIC | 1.45B | 1.24B | 1.22B | 1.18B | 1.12B |
| Retained Earnings | -1.30B | -1.25B | -1.20B | -1.16B | -1.11B |
| Treasury Stock & Other | -926.00K | -2.25M | -51.00K | -39.00K | -604.00K |
| Total Common Equity | 148.82M | -11.91M | 18.95M | 21.73M | 11.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 146.87M | 145.49M | 144.14M | 142.82M | 141.48M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 146.87M | 145.49M | 144.14M | 142.82M | 141.48M |
|
|
|||||
| Total Common Equity | 148.82M | -11.91M | 18.95M | 21.73M | 11.22M |
| Total Preferred Equity | 146.87M | 145.49M | 144.14M | 142.82M | 141.48M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 295.68M | 133.58M | 163.09M | 164.55M | 152.70M |
|
|
|||||